Management of Orthostatic Hypotension with Supine Hypertension

Introduction to Orthostatic Hypotension Management

The European Society of Cardiology recommends switching to long-acting dihydropyridine calcium channel blockers or RAS inhibitors as first-line therapy for patients requiring blood pressure control, particularly for those ≥85 years and those with orthostatic hypotension 1

Elevate the head of the bed by 10 degrees during sleep to prevent nocturnal polyuria, maintain favorable fluid distribution, and reduce supine hypertension 1
Increase fluid intake to 2-3 liters daily and salt intake to 6-9 grams daily (unless contraindicated by heart failure) 1, 3
Teach physical countermeasures: leg crossing, squatting, stooping, and muscle tensing during symptomatic episodes—particularly effective in patients under 60 years with prodromal symptoms 1
Use waist-high compression stockings (30-40 mmHg) and/or abdominal binders to reduce venous pooling 1
Recommend smaller, more frequent meals to reduce postprandial hypotension 1
Acute water ingestion (≥480 mL) provides temporary relief with peak effect at 30 minutes 1

Midodrine has the strongest evidence base among pressor agents with three randomized placebo-controlled trials demonstrating efficacy 1
Start midodrine at 2.5-5 mg three times daily, with the last dose taken at least 3-4 hours before bedtime (not after 6 PM) to prevent supine hypertension during sleep 1, 3
Titrate midodrine up to 10 mg three times daily as needed based on symptom response 3
Fludrocortisone acts through a complementary mechanism (sodium retention and vessel wall effects) compared to midodrine's alpha-1 adrenergic stimulation, and should be started at 0.05-0.1 mg once daily, with a maximum dose of 1.0 mg daily 1, 3

For patients with diabetes and autonomic neuropathy, expect a neurogenic pattern with blunted heart rate response, and assess for cardiovascular autonomic neuropathy 1, 3
For patients with Parkinson's disease, review antiparkinsonian medications as potential contributors, and consider droxidopa as a particularly effective treatment option 1, 3
For frail elderly patients (≥85 years), defer blood pressure-lowering treatment until office BP ≥140/90 mmHg, and use the "as low as reasonably achievable" (ALARA) principle rather than strict 130/80 mmHg targets 1, 4

The therapeutic objective is minimizing postural symptoms and improving functional capacity—NOT restoring normotension 1, 3
Measure BP after 5 minutes of lying/sitting, then at 1 and 3 minutes after standing, and document both supine and standing BP at every visit 1, 3
Follow-up schedule: initial follow-up within 1-2 weeks after medication changes, with ongoing assessment of orthostatic vital signs, symptom diary, falls assessment, and functional status 3